Upstream signaling pathways for proinflammatory cytokine production

Upstream signaling pathways for proinflammatory cytokine production" collectively refers to molecular cascades that are activated by extracellular and intracellular triggers (such as pathogen-associated molecular patterns, DAMPs, and cellular stress), resulting in the activation of transcription factors (such as NF-κB, AP-1, STATs) and the consequent transcription and release of proinflammatory cytokines (including TNF-α, IL-1β, IL-6, among others)[5][3][2][7]. These pathways often begin with receptors such as Toll-like receptors (TLRs), TNF receptors, and interleukin-1 receptors, which activate intermediate adaptors (e.g., MyD88, TRIF, TRAF6, TAK1) and kinase cascades (including MAPK, JAK/STAT, and IKK complexes), culminating in cytokine gene expression[2][5][6][3][7]. These networks are critical for host defense, inflammation, and the pathogenesis of diseases such as sepsis, autoimmune diseases, COVID-19, and cancer[1][4][5][7]. However, this is not the name of a discrete molecule or a druggable target, but rather a conceptual grouping encompassing many distinct proteins and complexes, each of which could be evaluated separately for therapeutic relevance.